MedPath

Withings Devices Follow-up Study - Hypertension

Conditions
Hypertension
Registration Number
NCT06692413
Lead Sponsor
Withings
Brief Summary

The primary objective is to evaluate the accuracy to predict uncontrolled hypertension with Withings device data.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • Male or female who are 21 years of age or older,
  • Participant living in the United States,
  • Participant with data recorded in WITHINGS database,
  • Active WITHINGS device users having at least 2 years of data,
  • Subject able to read, understand, and provide written informed consent,
  • Subject willing and able to participate in the study procedures as described in the consent form,
  • Subject able to communicate effectively with and willing to follow instructions from the study staff.
Exclusion Criteria
  • Minors under 21 years old,
  • Subject who refused to participate in the study,
  • Subject who did not reply to the questionnaire,
  • Subject who objected to the processing of his or her data after the start of the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prediction of uncontrolled hypertension2 years

Correlation between uncontrolled hypertension, Withings data, and survey answers

Secondary Outcome Measures
NameTimeMethod
Correlation between Framingham risk score and EQ-5D-5L answers and Withings data2 years

Correlation between Framingham risk score and EQ-5D-5L answers and Withings data

Number of Questionnaires answers per participant2 years

Number of Questionnaires answers per participant

Trial Locations

Locations (1)

Yale University Medical School, Department of Neurology

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath